These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15841074)

  • 1. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ.
    Wülfing P; Kersting C; Buerger H; Mattsson B; Mesters R; Gustmann C; Hinrichs B; Tio J; Böcker W; Kiesel L
    Br J Cancer; 2005 May; 92(9):1720-8. PubMed ID: 15841074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
    Hieken TJ; Farolan M; D'Alessandro S; Velasco JM
    Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
    Takahashi Y; Cleary KR; Mai M; Kitadai Y; Bucana CD; Ellis LM
    Clin Cancer Res; 1996 Oct; 2(10):1679-84. PubMed ID: 9816116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.
    Brown LF; Berse B; Jackman RW; Tognazzi K; Guidi AJ; Dvorak HF; Senger DR; Connolly JL; Schnitt SJ
    Hum Pathol; 1995 Jan; 26(1):86-91. PubMed ID: 7821921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
    Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues.
    Pallares J; Rojo F; Iriarte J; Morote J; Armadans LI; de Torres I
    Histol Histopathol; 2006 Aug; 21(8):857-65. PubMed ID: 16691538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey.
    Wei P; Yu FQ; Chen XL; Tao SX; Han CS; Liu YX
    Placenta; 2004; 25(2-3):184-96. PubMed ID: 14972451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops.
    de Jong JS; van Diest PJ; van der Valk P; Baak JP
    J Pathol; 1998 Jan; 184(1):44-52. PubMed ID: 9582526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of lymphangiogenic and angiogenic factors in a model of breast ductal carcinoma in situ.
    Yu M; Tang Z; Alousi S; Berk RS; Miller F; Kosir MA
    Am J Surg; 2007 Nov; 194(5):594-9. PubMed ID: 17936419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas.
    Okada K; Osaki M; Araki K; Ishiguro K; Ito H; Ohgi S
    Anticancer Res; 2005; 25(4):3003-9. PubMed ID: 16080559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
    Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
    Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.
    Guidi AJ; Schnitt SJ; Fischer L; Tognazzi K; Harris JR; Dvorak HF; Brown LF
    Cancer; 1997 Nov; 80(10):1945-53. PubMed ID: 9366297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
    Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
    Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
    Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.